Iron supplementation to treat anaemia in adult critical care patients: A systematic review and meta-analysis

Critical Care

Volumn 20, Issue 1, 2016, Pages

  Shah, Akshay ^a   Roy, Noémi B ^b   McKechnie, Stuart ^a   Doree, Carolyn ^c   Fisher, Sheila A ^c   Stanworth, Simon J ^a,d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anaemia; Haemoglobin; Iron; Meta analysis; Red blood cell; Transfusion

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON;

ABDOMINAL CRAMP; ALLOTRANSPLANTATION; ANEMIA; ARTICLE; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MINERAL SUPPLEMENTATION; MORTALITY RATE; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VOMITING;

EID: 84992145740     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-016-1486-z     Document Type: Article

References (30)

1. Walsh TS, Wyncoll DA, Stanworth SJ. Managing anaemia in critically ill adults. BMJ. 2010;341:547-51.
2. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D. ABC (Anemia and Blood Transfusion in Critical Care) Investigators: anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-507.
3. Walsh TS, Lee RJ, Maciver CR, et al. Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med. 2006;32:100-9.
4. Westbrook A, Pettila V, Nichol A, Blood Observational Study Investigators of ANZICS Clinical Trials Group, et al. Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med. 2010;36:1138-46.
5. Walsh TS, Garrioch M, Maciver C, Audit of Transfusion in Intensive Care in Scotland Study, et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion. 2004;44:1405-11.
6. McQuilten ZK, Schembri N, Polizotto MN, et al. Hospital blood bank information systems accurately reflect patient transfusion: results of a validation study. Transfusion. 2011;51:948-68.
7. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544-52.
8. Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfus Med Revs. 2011;25:89-101.
9. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667-74.
10. Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences and management. Am J Resp Crit Care Med. 2012;185:1049-57.
11. Litton E, Xiao J, Ho KM. Safety and efficacy on intravenous iron therapy in reducing requirement for allogeneic blood transfusion: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822.
12. Shah A, Roy N, McKechnie S, Stanworth SJ, Doree C, Fisher S. Iron supplementation to treat anaemia in adult critical care patients. PROSPERO 2015: CRD42015016627. Available from http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD4201501662. Accessed 2 Mar 2015.
13. Albaramki J, Hodson EM, Craig JC. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2012;1:CD007857.
14. Reveiz L, Gyte GML, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011;10:CD003094.
15. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett; 1996.
16. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons; 2008. p. 187-241.
17. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014
18. Higgins JPT, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales. Stat Med. 2008;27:6072-92.
19. Garrido-Martin P, Nassar-Mansur MI, Llana-Ducros R, et al. The effect of intravenous and oral iron administration of perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg. 2012;15:1013-8.
20. Higgins JT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
21. Madi-Jebara S, Sleilaty GS, Achouch PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18:59-63.
22. Pieracci FM, Henderson P, Rodney JR, et al. Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt). 2009;10:9-19.
23. Pieracci FM, Stovall RT, Jaouen B, et al. A Multicentre, Randomized Clinical Trial of IV Iron Supplementation for Anemia of Traumatic Critical Illness. Crit Care Med. 2014;42:2048-57.
24. van Iperen CE, Gaillard CAJM, Kraaijenhagen RJ, et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med. 2000;28:2773-8.
25. Litton E, Baker S, Erber W, et al. The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia. Crit Care Resusc. 2014;16:285-90.
26. Clevenger C, Gurusamy K, Klein AK, et al. Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review. Eur J Heart Fail. 2016. doi: 10.1002/ejhf.514.
27. Fishbane S. Review of issues relating to iron and infection. Am J Kidney Dis. 1999;34 Suppl 2:S47-52.
28. Goodnough LT. Iron deficiency syndromes and iron restricted erythropoiesis. Transfusion. 2012;52:1584-92.
29. Pasricha SR, Atkinson SA, Armitage AE, et al. Expression of the Iron Hormone Hepcidin Distinguishes Different Types of Anemia in African Children. Sci Transl Med. 2014;6:235re3.
30. Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anaemia. Am J Hematol. 2013;88:97-101.